Clinical Protocol to Investigate the Efficacy of Recombinant Human Leptin (Metreleptin) in Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) Associated With Lipodystrophy

Name: Clinical Protocol to Investigate the Efficacy of Recombinant Human Leptin (Metreleptin) in Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) Associated With Lipodystrophy
License: Public Domain

University of Michigan

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

fatty liver disease, nonalcoholic, nonalcoholic steatohepatitis, lipodystrophy

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 314262
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.